About
Curonix is a medical technology company based in Delaware, with its headquarters in Pompano Beach, Florida. The company specializes in advanced, non-opioid solutions for chronic pain relief, particularly for patients who have not found success with traditional treatments. Curonix employs between 100 to 249 people and has an estimated revenue of $5 to $10 million. The flagship product, the Freedom® Peripheral Nerve Stimulator (PNS) System, is a minimally invasive implant designed to provide lasting relief from chronic pain. It features proprietary HF-EMC technology, allowing for nerve-specific programming through NervPulse™ Therapy, which personalizes stimulation for optimal pain relief. Clinical studies have shown significant improvements in pain and medication use among patients using the Freedom® System. Curonix is committed to supporting both patients and healthcare providers through innovative solutions, clinical education, and ongoing research to enhance pain management practices.
Technologies
Keywords
Company Information
- Employees200
- Founded2022
- Annual Revenue$122000000
- Total Funding$50000000
Location
1310 Park Central Blvd S, Pompano Beach, Florida, United States, 33064
